Jamieson Bondarenko Insider Profile
4 Followers
Jamieson Bondarenko, Director at BriaCell Therapeutics, holds 169.86K shares in BriaCell Therapeutics (Ticker: TSE:BCT). Most recently, Jamieson Bondarenko Bought 28,000 shares of BriaCell Therapeutics on Dec 28, 2022 for an estimated value of C$128.24K.
Jamieson Bondarenko's Trading History
| BCTBriaCell Therapeutics | Dec 28, 2022 | Director | Informative Buy | 128.24K | C$803.42K | |||||||||||||||||||||||||||||||||||||||||||
TSE:BCT Insider Shares: 169.86K (109.46%)
| ||||||||||||||||||||||||||||||||||||||||||||||||
You May Also Like
Jamieson Bondarenko insider profile FAQ
What is the percentage of profitable transactions made by Jamieson Bondarenko?
The percentage of profitable transactions made by Jamieson Bondarenko is 11%.
What is the average return per transaction made by Jamieson Bondarenko?
The average return per transaction made by Jamieson Bondarenko is -48.90%.
What stocks does Jamieson Bondarenko hold?
Jamieson Bondarenko holds: TSE:BCT stocks.
What was Jamieson Bondarenko’s latest transaction?
Jamieson Bondarenko’s latest transaction was an Informative Buy of C$128.24K.
What was Jamieson Bondarenko's most profitable transaction?
Jamieson Bondarenko’s most profitable transaction was an Informative Buy of TSE:BCT stock on December 28, 2022. The return on the trade was 18.20%.
What is Jamieson Bondarenko's role in BriaCell Therapeutics?
Jamieson Bondarenko's role in BriaCell Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
